[FATE] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -109.05%
YoY- -120.54%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 13,412 11,142 15,896 7,558 5,465 2,515 2,802 184.29%
PBT -55,133 -45,089 -53,112 -58,684 -28,072 -33,520 -28,302 56.04%
Tax 8,354 -1,121 -861 0 635 0 691 427.55%
NP -55,133 -45,089 -53,112 -58,684 -28,072 -33,520 -28,302 56.04%
Tax Rate - - - - - - - -
Total Cost 68,545 56,231 69,008 66,242 33,537 36,035 31,104 69.42%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -411.07 -404.68 -334.12 -776.45 -513.67 -1,332.80 -1,010.06 -45.11%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.58 -0.48 -0.61 -0.68 -0.35 -0.44 -0.37 34.98%
EPS Diluted -0.58 -0.48 -0.61 -0.68 -0.35 -0.44 -0.37 34.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.